(E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide
TL;DR: (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide (CAS 1006503-02-1) is a chemical compound with molecular formula C18H17N5O4 and molecular weight 367.13 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-[(E)-(5-methylfuran-2-yl)methylideneamino]-4-[(5-methyl-3-nitropyrazol-1-yl)methyl]benzamide
Also Known As: (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide, N'-[(E)-(5-methylfuran-2-yl)methylidene]-4-[(5-methyl-3-nitro-1H-pyrazol-1-yl)methyl]benzohydrazide, N-[(E)-(5-methylfuran-2-yl)methylideneamino]-4-[(5-methyl-3-nitropyrazol-1-yl)methyl]benzamide
| Molecular Formula | C18H17N5O4 |
|---|---|
| Molecular Weight | 367.13 g/mol |
| LogP | 2.81334 |
| Topological Polar Surface Area | 115.56 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Exact Mass | 367.12805 |
| Heavy Atoms | 27 |
| Complexity | 1001.1909 |
Chemical Identifiers
| CAS Number | 1006503-02-1 |
|---|---|
| SMILES | CC1=CC=C(O1)/C=N/NC(=O)C2=CC=C(C=C2)CN3C(=CC(=N3)[N+](=O)[O-])C |
Product Overview
(E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide (CAS 1006503-02-1), with molecular formula C18H17N5O4 and molecular weight 367.13 g/mol. IUPAC: N-[(E)-(5-methylfuran-2-yl)methylideneamino]-4-[(5-methyl-3-nitropyrazol-1-yl)methyl]benzamide.
Chemical Property Profile of (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide
Property Insights of (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide
The XLogP value of 2.81334 suggests moderate lipophilicity, balancing water solubility and membrane permeability for (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide. The TPSA of 115.56 Ų falls within the moderate polarity range, balancing permeability and solubility for (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide. Following Lipinski's Rule of Five, (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide has 1 hydrogen bond donor(s) and 6 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide?
The CAS number of (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide is 1006503-02-1.
What is the molecular formula of (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide?
The molecular formula of (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide is C18H17N5O4.
What is the molecular weight of (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide?
The molecular weight of (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide is 367.13 g/mol.
Where can I buy (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide?
You can request a quote for (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide?
Yes, KEHONG BIO provides custom synthesis services for (E)-4-((5-methyl-3-nitro-1H-pyrazol-1-yl)methyl)-N'-((5-methylfuran-2-yl)methylene)benzohydrazide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.